Pharmarise Holdings Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3802320006
JPY
517.00
36 (7.48%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Nov'25
Aug'25
May'25
Feb'25
Nov'24
Aug'24
May'24
Net Sales
16,849.00
16,753.00
16,929.00
16,035.00
15,313.00
15,231.00
13,792.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
16,849.00
16,753.00
16,929.00
16,035.00
15,313.00
15,231.00
13,792.00
Raw Material Cost
14,721.00
14,715.00
14,710.00
13,926.00
13,394.00
13,275.00
11,939.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
62.00
61.00
59.00
51.00
38.00
30.00
24.00
Selling and Distribution Expenses
1,882.00
1,885.00
2,021.00
2,113.00
1,871.00
1,903.00
1,797.00
Other Expenses
-6.20
-6.10
-5.90
-5.10
-3.80
-3.00
-2.10
Total Expenditure (Excl Depreciation)
16,603.00
16,600.00
16,731.00
16,039.00
15,265.00
15,178.00
13,739.00
Operating Profit (PBDIT) excl Other Income
246
153
198
-4
48
53
53
Other Income
6.00
39.00
17.00
8.00
-5.00
1.00
3.00
Operating Profit (PBDIT)
642.00
568.00
623.00
386.00
402.00
398.00
358.00
Interest
62.00
61.00
59.00
51.00
38.00
30.00
24.00
Exceptional Items
45.00
1.00
-118.00
-15.00
5.00
-1.00
-649.00
Gross Profit (PBDT)
2,128.00
2,038.00
2,219.00
2,109.00
1,919.00
1,956.00
1,853.00
Depreciation
390.00
376.00
408.00
382.00
359.00
344.00
302.00
Profit Before Tax
237.00
131.00
36.00
-62.00
12.00
22.00
-618.00
Tax
108.00
153.00
135.00
99.00
0.00
156.00
-88.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
129.00
-19.00
-96.00
-158.00
17.00
-131.00
-528.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
129.00
-19.00
-96.00
-158.00
17.00
-131.00
-528.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.00
-3.00
-1.00
-5.00
-5.00
-2.00
-1.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
128.00
-22.00
-97.00
-163.00
12.00
-133.00
-529.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,815.00
6,617.00
6,869.00
6,948.00
7,091.00
7,004.00
7,362.00
Earnings per share (EPS)
10.93
-1.58
-8.36
-14.0
1.58
-11.65
-46.96
Diluted Earnings per share
10.93
-1.58
-8.36
-14.0
1.58
-11.65
-46.96
Operating Profit Margin (Excl OI)
1.46%
0.91%
1.17%
-0.02%
0.31%
0.35%
0.38%
Gross Profit Margin
3.72%
3.03%
2.62%
2.0%
2.42%
2.4%
-2.29%
PAT Margin
0.77%
-0.11%
-0.57%
-0.99%
0.11%
-0.86%
-3.83%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Nov 2025 is 0.57% vs -1.04% in Aug 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Nov 2025 is 681.82% vs 77.32% in Aug 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Nov 2025 is 20.23% vs -12.71% in Aug 2025

stock-summary

Interest

QoQ Growth in quarter ended Nov 2025 is 1.64% vs 3.39% in Aug 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Nov 2025 has improved from Aug 2025

Compare Quarterly Results Of Pharmarise Holdings Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
16,849.00
10.00
16,839.00
168,390.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
16,849.00
10.00
16,839.00
168,390.00%
Raw Material Cost
14,721.00
1.58
14,719.42
931,608.86%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
62.00
0.00
62.00
Selling and Distribution Expenses
1,882.00
45.19
1,836.81
4,064.64%
Other Expenses
-6.20
6.55
-12.75
-194.66%
Total Expenditure (Excl Depreciation)
16,603.00
112.27
16,490.73
14,688.46%
Operating Profit (PBDIT) excl Other Income
246.00
-102.27
348.27
340.54%
Other Income
6.00
35.65
-29.65
-83.17%
Operating Profit (PBDIT)
642.00
-66.62
708.62
1,063.67%
Interest
62.00
0.00
62.00
Exceptional Items
45.00
0.00
45.00
Gross Profit (PBDT)
2,128.00
8.42
2,119.58
25,173.16%
Depreciation
390.00
0.00
390.00
Profit Before Tax
237.00
-66.63
303.63
455.70%
Tax
108.00
0.25
107.75
43,100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
129.00
-66.88
195.88
292.88%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
129.00
-66.88
195.88
292.88%
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.00
0.00
-1.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
128.00
-66.88
194.88
291.39%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
6,815.00
1,653.27
5,161.73
312.21%
Earnings per share (EPS)
10.93
-5.26
16.19
307.79%
Diluted Earnings per share
10.93
-5.26
16.19
307.79%
Operating Profit Margin (Excl OI)
1.46%
-1,022.74%
0.00
1,024.20%
Gross Profit Margin
3.72%
-666.26%
0.00
669.98%
PAT Margin
0.77%
-668.77%
0.00
669.54%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,684.90 Million
in Nov 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Nov 2025 is 0.57% vs -1.04% in Aug 2025

stock-summary

YoY Growth in quarter ended Nov 2025 is 10.03% vs 13.62% in Nov 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 12.80 Million
in Nov 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Nov 2025 is 681.82% vs 77.32% in Aug 2025

stock-summary

YoY Growth in quarter ended Nov 2025 is 966.67% vs -92.26% in Nov 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 63.60 Million
in Nov 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Nov 2025 is 20.23% vs -12.71% in Aug 2025

stock-summary

YoY Growth in quarter ended Nov 2025 is 56.27% vs -39.43% in Nov 2024

Quarterly - Interest
Interest 6.20 Million
in Nov 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Nov 2025 is 1.64% vs 3.39% in Aug 2025

stock-summary

YoY Growth in quarter ended Nov 2025 is 63.16% vs 153.33% in Nov 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.46%
in Nov 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Nov 2025 has improved from Aug 2025

stock-summary

YoY Growth in quarter ended Nov 2025 has improved from Nov 2024